Clinical Pharmacology and Therapeutics - Table of Contents alert Volume 96 Issue 3

If you are unable to see the message below, click here to view.

Advertisement Multiplexed Immunoassay Services for Cardiovascular Research Myriad RBM provides quantitative, multiplexed immunoassay services for dozens of blood-based markers with purported importance in cardiovascular conditions. Referenced in nearly 50 publications, Myriad RBM's cardiovascular biomarker panels have shown to be invaluable tools for early disease detection to monitoring efficacy and the development of complications following specific disease interventions.   Explore the utility of our biomarker solutions. Download Myriad RBM's Cardiovascular Application Notes TABLE OF CONTENTS Volume 96, Issue 3 (September 2014) In this issue In This Issue Editorial News & Views Perspectives Discovery & Development Clinical Trial Research Corrigendum Also new AOP Sign up for CPT: Pharmacometrics & Systems Pharmacology e-alerts Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Have you heard the latest?  Listen to the latest podcast from Clinical Pharmacology & Therapeutics and join us as we delve into the advances in the nature, action, efficacy, and evaluation of therapeutics in this cross-disciplinary field of experimental and clinical medicine. Each podcast features highlighted content from Clinical Pharmacology & Therapeutics. In This Issue Top In This Issue Clin Pharmacol Ther 2014 96: 279; 10.1038/clpt.2014.149 Full Text Editorial Top Biotransformation S Ito Clin Pharmacol Ther 2014 96: 281-283; 10.1038/clpt.2014.133 Abstract | Full Text News & Views Top HIGHLIGHTS Clin Pharmacol Ther 2014 96: 284-285; 10.1038/clpt.2014.148 Full Text ASCPT NEWS Clin Pharmacol Ther 2014 96: 286-289; 10.1038/clpt.2014.135 Full Text Perspectives Top OPINION A Question-Based Approach to Adopting Pharmacogenetics to Understand Risk for Clinical Variability in Pharmacokinetics in Early Drug Development R Evers, R L Blanchard, A W Warner, D Cutler, N G B Agrawal and P M Shaw Clin Pharmacol Ther 2014 96: 291-295; 10.1038/clpt.2014.98 Abstract | Full Text COMMENTARIES Genetic Markers of Cisplatin-Induced Hearing Loss in Children B C Carleton, C J Ross, K Pussegoda, A P Bhavsar, H Visscher, J W Lee, B Brooks, S R Rassekh, M-P P Dubé and M R Hayden Clin Pharmacol Ther 2014 96: 296-298; 10.1038/clpt.2014.92 Abstract | Full Text COMMENTARY ITC Commentary on the Prediction of Digoxin Clinical Drug–Drug Interactions from In Vitro Transporter Assays C A Lee, J C Kalvass, A Galetin and M J Zamek-Gliszczynski ; on behalf of the International Transporter Consortium Clin Pharmacol Ther 2014 96: 298-301; 10.1038/clpt.2014.94 Abstract | Full Text LETTERS TO THE EDITOR The Failing Right Heart: The Neglected Ventricle? V Ziesenitz, D Köhler and M Gorenflo Clin Pharmacol Ther 2014 96: 302; advance online publication, May 13, 2014; 10.1038/clpt.2014.108 Full Text Response to “The Failing Right Heart: The Neglected Ventricle?” J Vincent Clin Pharmacol Ther 2014 96: 302-303; advance online publication, June 13, 2014; 10.1038/clpt.2014.132 Full Text Discovery & Development Top TRANSLATION Individualizing the Use of Medications in Children: Making Goldilocks Happy J S Leeder, J T Brown and S E Soden Clin Pharmacol Ther 2014 96: 304-306; advance online publication, June 13, 2014; 10.1038/clpt.2014.130 Abstract | Full Text DEVELOPMENT Prerequisites to Implementing a Pharmacogenomics Program in a Large Health-Care System K D Levy, B S Decker, J S Carpenter, D A Flockhart, P R Dexter, Z Desta and T C Skaar Clin Pharmacol Ther 2014 96: 307-309; advance online publication, May 7, 2014; 10.1038/clpt.2014.101 Abstract | Full Text Human iPSC-Derived Miniature Organs: A Tool for Drug Studies T Takebe and H Taniguchi Clin Pharmacol Ther 2014 96: 310-313; advance online publication, May 21, 2014; 10.1038/clpt.2014.110 Abstract | Full Text Clinical Trial Top A Compartmental Pharmacokinetic Evaluation of Long-Acting Rilpivirine in HIV-Negative Volunteers for Pre-Exposure Prophylaxis A G A Jackson, L J Else, P M M Mesquita, D Egan, D J Back, Z Karolia, L Ringner-Nackter, C J Higgs, B C Herold, B G Gazzard and M Boffito Clin Pharmacol Ther 2014 96: 314-323; advance online publication, May 26, 2014; 10.1038/clpt.2014.118 Abstract | Full Text Research Top REVIEW Pharmacogenomics of Human Uridine Diphospho-Glucuronosyltransferases and Clinical Implications C Guillemette, É Lévesque and M Rouleau Clin Pharmacol Ther 2014 96: 324-339; advance online publication, June 12, 2014; 10.1038/clpt.2014.126 Abstract | Full Text Functional Gene Variants of CYP3A4 A N Werk and I Cascorbi Clin Pharmacol Ther 2014 96: 340-348; advance online publication, June 13, 2014; 10.1038/clpt.2014.129 Abstract | Full Text ARTICLES Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots OPEN M Bosilkovska, C F Samer, J Déglon, M Rebsamen, C Staub, P Dayer, B Walder, J A Desmeules and Y Daali Clin Pharmacol Ther 2014 96: 349-359; advance online publication, April 10, 2014; 10.1038/clpt.2014.83 Abstract | Full Text Inflammation-Related Genetic Variations and Survival in Patients With Advanced Non–Small Cell Lung Cancer Receiving First-Line Chemotherapy X Pu, M A T Hildebrandt, C Lu, J A Roth, D J Stewart, Y Zhao, R S Heist, Y Ye, D W Chang, L Su, J D Minna, S M Lippman, M R Spitz, D C Christiani and X Wu Clin Pharmacol Ther 2014 96: 360-369; advance online publication, April 22, 2014; 10.1038/clpt.2014.89 Abstract | Full Text Genetic Variants in Transcription Factors Are Associated With the Pharmacokinetics and Pharmacodynamics of Metformin S Goswami, S W Yee, S Stocker, J D Mosley, M Kubo, R Castro, J A  Mefford, C Wen, X Liang, J Witte, C Brett, S Maeda, M D  Simpson, M M Hedderson, R L Davis, D M Roden, K M Giacomini and R M Savic Clin Pharmacol Ther 2014 96: 370-379; advance online publication, May 22, 2014; 10.1038/clpt.2014.109 Abstract | Full Text The Posology of Oseltamivir in Infants With Influenza Infection Using a Population Pharmacokinetic Approach M A Kamal, E P Acosta, D W Kimberlin, L Gibiansky, P Jester, V Niranjan, B Rath, B Clinch, P J Sánchez, K Ampofo, R Whitley and C R Rayner Clin Pharmacol Ther 2014 96: 380-389; advance online publication, May 27, 2014; 10.1038/clpt.2014.120 Abstract | Full Text Retreatment With Varenicline for Smoking Cessation in Smokers Who Have Previously Taken Varenicline: A Randomized, Placebo-Controlled Trial OPEN D Gonzales, P Hajek, L Pliamm, K Nackaerts, L-J Tseng, T D McRae and J Treadow Clin Pharmacol Ther 2014 96: 390-396; advance online publication, June 9, 2014; 10.1038/clpt.2014.124 Abstract | Full Text Corrigendum Top Corrigendum: Patients Benefit From Genetics-Guided Coumarin Anticoagulant Therapy Clin Pharmacol Ther 2014 96: 397; 10.1038/clpt.2014.142 Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Clinical Pharmacology & Therapeutics. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.